[424B2] Inverse VIX Short-Term Futures ETNs due March 22, 2045 Prospectus Supplement
Rhea-AI Filing Summary
JPMorgan Chase Financial Company LLC is marketing Auto-Callable Contingent Interest Notes due 2 July 2030 that are unsecured, unsubordinated obligations of the issuer and are fully and unconditionally guaranteed by JPMorgan Chase & Co.
The notes are linked to the MerQube US Large-Cap Vol Advantage Index (MQUSLVA), whose performance is reduced by a 6.0% p.a. daily deduction. Investors receive a contingent semi-annual coupon of at least 8.25% (16.50% p.a.) for any Review Date on which the Index closes at or above the Interest Barrier of 70% of the Initial Value. If on any Review Date other than the first or final the Index closes at or above the Call Value of 90%, the notes are redeemed early at par plus the applicable coupon. The first potential call date is 29 June 2026.
If the notes are not called, principal is protected only down to the Trigger Value of 50%. Should the Index close below that level on the final Review Date, investors will be exposed 1-for-1 to the Index decline, leading to a loss of more than 50% and potentially all of the principal.
Key economic terms (per $1,000 face): estimated value ≈ $937 at current market levels (not less than $900 at pricing); selling commission ≤ $5; minimum denomination $1,000; CUSIP 48136FAB8. The notes price on or about 27 June 2025 and settle 2 July 2025.
Primary risks highlighted include credit exposure to JPMorgan entities, the drag from the 6% daily deduction, potential absence of coupon payments, leverage mechanisms within the Index (0–500% futures exposure) and the possibility of significant principal loss. The notes are not bank deposits and are not FDIC-insured.
Positive
- High contingent coupon of at least 16.5% p.a. offers meaningful income potential if index remains above the 70% barrier.
- Automatic call at 90% of initial allows early redemption at par plus coupon, potentially enhancing annualised yield.
- Full guarantee by JPMorgan Chase & Co. adds a strong investment-grade credit backstop relative to many structured issuers.
Negative
- 6.0% daily deduction on the underlying index is a constant drag that can materially reduce performance and coupon frequency.
- Principal at risk below 50% trigger; investors could lose more than half, up to the entire investment.
- Estimated value ($937) materially below par, indicating an issuer spread and potential negative carry for early secondary sellers.
- Coupon is not fixed; payments cease if the index closes below the 70% barrier on a review date.
- Credit exposure to JPMorgan entities; payments depend on issuer and guarantor solvency.
Insights
TL;DR – High coupon comes with 6% index drag, 50% soft floor and JPM credit risk; overall neutral for investors.
The instrument offers an eye-catching minimum 16.5% annual contingent coupon and an automatic call feature at 90% of initial index level after one year. These terms are made feasible largely because the underlying index embeds a 6% yearly deduction and variable leverage, reducing expected returns versus the S&P 500. Principal is exposed below a 50% trigger, so a deep equity drawdown could erode capital. Estimated fair value of $937 indicates a 6.3% fee spread versus par, typical for retail structured notes. For JPM shareholders the effect is de minimis; for prospective note buyers risk-adjusted value appears balanced, hence a neutral impact.
TL;DR – Product concentrates market, leverage and issuer credit risks; suitability limited to yield-seeking investors.
The note’s payoff exposes holders to three stacked risks: (1) JPMorgan default, (2) index shortfall from daily 6% fee plus up-to-5× leveraged futures exposure and (3) coupon suspension whenever MQUSLVA < 70% of initial. The 50% trigger offers only partial protection; a 40% final index level would translate to a 60% capital loss. Investors also face reinvestment risk if the note auto-calls early. While the coupon looks generous, it compensates for these embedded risks rather than providing excess economic value. Overall market impact is minor; individual suitability depends on risk tolerance and portfolio context.















